The Ensign Group, Inc.
$190
▼
-0.91%
2026-04-22 10:12:13
ensigngroup.net
NMS: ENSG
Explore The Ensign Group, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$11.11 B
Current Price
$190
52W High / Low
$218 / $118.73
Stock P/E
32.56
Book Value
$38.71
Dividend Yield
0.13%
ROCE
9.31%
ROE
16.89%
Face Value
—
EPS
$5.84
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
46,000
Beta
0.82
Debt / Equity
98.7
Current Ratio
1.42
Quick Ratio
1.42
Forward P/E
24.16
Price / Sales
2.3
Enterprise Value
$13.12 B
EV / EBITDA
24.81
EV / Revenue
2.59
Rating
Buy
Target Price
$220.4
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Basel Medical Group Ltd | $0.62 | — | $10.73 M | — | -25.54% | -1.64% | $9.4 / $0.49 | $0.23 |
| 2. | Encompass Health Corporation | $103.27 | 18.68 | $10.28 B | 0.72% | 16.84% | 24.82% | $127.99 / $92.77 | $24.38 |
| 3. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 4. | InnovAge Holding Corp. | $7.95 | 172.72 | $1.12 B | — | -4.46% | 1.18% | $10.69 / $2.6 | $1.89 |
| 5. | LifeStance Health Group, Inc. | $6.92 | 277.93 | $2.69 B | — | 1.24% | 0.65% | $8.09 / $3.74 | $3.92 |
| 6. | Addus HomeCare Corporation | $93.52 | 18.23 | $1.75 B | — | 10.76% | 9.33% | $124.44 / $90.89 | $59.84 |
| 7. | Cryo-Cell International, Inc. | $3.56 | — | $27.71 M | 11.63% | 11.54% | 15.27% | $6.35 / $2.72 | $-2.31 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 1.36 B | 1.3 B | 1.23 B | 1.17 B | 1.13 B |
| Operating Profit | 123.81 M | 96.22 M | 103.9 M | 101.37 M | 100.78 M |
| Net Profit | 95.45 M | 83.84 M | 84.4 M | 80.28 M | 79.69 M |
| EPS in Rs | 1.63 | 1.44 | 1.44 | 1.37 | 1.36 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 5.06 B | 4.26 B | 3.73 B | 3.03 B |
| Operating Profit | 425.31 M | 358.3 M | 255.37 M | 296.82 M |
| Net Profit | 343.97 M | 297.97 M | 209.4 M | 224.68 M |
| EPS in Rs | 5.89 | 5.1 | 3.58 | 3.85 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.46 B | 4.67 B | 4.18 B | 3.45 B |
| Total Liabilities | 3.23 B | 2.83 B | 2.68 B | 2.2 B |
| Equity | 2.23 B | 1.84 B | 1.49 B | 1.25 B |
| Current Assets | 1.27 B | 1.16 B | 1.05 B | 781.12 M |
| Current Liabilities | 894.35 M | 743.43 M | 734.75 M | 582.07 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 564.27 M | 347.19 M | 376.67 M | 272.51 M |
| Investing CF | -513.18 M | -390.05 M | -182.7 M | -186.18 M |
| Financing CF | -11.81 M | -2.16 M | -0.61 M | -32.26 M |
| Free CF | 370.71 M | 188.95 M | 270.49 M | 184.97 M |
| Capex | -193.56 M | -158.24 M | -106.18 M | -87.55 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 14.24% | 23.27% | — | — |
| Earnings Growth % | 42.3% | -6.8% | — | — |
| Profit Margin % | 6.99% | 5.61% | 7.43% | — |
| Operating Margin % | 8.41% | 6.85% | 9.81% | — |
| Gross Margin % | 15.67% | 15.84% | 17.12% | — |
| EBITDA Margin % | 11.23% | 9.47% | 11.91% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-31 | $0.065 |
| 2025-12-31 | $0.065 |
| 2025-09-30 | $0.063 |
| 2025-06-30 | $0.063 |
| 2025-03-31 | $0.063 |
Stock Splits
No stock split history available.